Abiopharma

News list

Director Schalop Lee Troy 🟢 acquired 5.0K shares (1 derivative) of Lantern Pharma Inc. (LTRN) at $4.46 Filing ID: 025000

Full text

News bot Aug. 20, 2025, 10:26 p.m.
🔍 Schalop Lee Troy (Director)

Company: Lantern Pharma Inc. (LTRN)

Report Date: 2025-08-19
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,000
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Stock Option (Right to Buy) at $4.46 per share (Derivative)
  Date: 2025-08-19 | Code: A | Expires: 2035-08-18 | equity_swap_involved: 0 | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.